Exosomes mediated fibrogenesis in dilated cardiomyopathy through a MicroRNA pathway

Xuebin Fu,Rachana Mishra,Ling Chen,Mir Yasir Arfat,Sudhish Sharma,Tami Kingsbury,Muthukumar Gunasekaran,Progyaparamita Saha,Charles Hong,Peixin Yang,Deqiang Li,Sunjay Kaushal

DOI: https://doi.org/10.1016/j.isci.2023.105963

IF: 5.8

2023-01-13

iScience

Abstract:Cardiac fibrosis is a hallmark in late-stage familial dilated cardiomyopathy (DCM) patients, although the underlying mechanism remains elusive. Cardiac exosomes (Exos) have been reported relating to fibrosis in ischemic cardiomyopathy. Thus, we investigated whether Exos secreted from the familial DCM cardiomyocytes could promote fibrogenesis. Using human iPSCs differentiated cardiomyocytes we isolated Exos of angiotensin II stimulation conditioned media from either DCM or control (CTL) cardiomyocytes. Of interest, cultured cardiac fibroblasts had increased fibrogenesis following exposure to DCM-Exos rather than CTL-Exos. Meanwhile, injecting DCM-Exos into mouse hearts enhanced cardiac fibrosis and impaired cardiac function. Mechanistically, we identified the upregulation of miRNA-218-5p in the DCM-Exos as a critical contributor to fibrogenesis. MiRNA-218-5p activated TGF-β signaling via suppression of TNFAIP3, a master inflammation inhibitor. In conclusion, our results illustrate a profibrotic effect of cardiomyocytes-derived Exos that highlights an additional pathogenesis pathway for cardiac fibrosis in DCM.